SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-069958
Filing Date
2018-11-27
Accepted
2018-11-27 06:01:28
Documents
5
Period of Report
2018-11-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-40386_28k.htm 8-K 23270
2 EX-99.1 a18-40386_2ex99d1.htm EX-99.1 48250
3 GRAPHIC g403862mmi001.jpg GRAPHIC 3261
4 GRAPHIC g403862mmi002.jpg GRAPHIC 2908
5 GRAPHIC g403862mmi003.jpg GRAPHIC 26463
  Complete submission text file 0001104659-18-069958.txt   117996
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36562 | Film No.: 181201900
SIC: 2834 Pharmaceutical Preparations